What is he best known for?
The fields of study he is best known for:
His primary scientific interests are in Biochemistry, Amyloid, P3 peptide, Molecular biology and Fibril.
David B. Teplow combines subjects such as Cell culture and Amyloid precursor protein with his study of Biochemistry.
The concepts of his Amyloid study are interwoven with issues in Biophysics, Amyloid beta and Circular dichroism.
His P3 peptide research includes elements of Neuropil, Biochemistry of Alzheimer's disease, Neuroscience and Neurotoxicity.
His study on Cleavage is often connected to PrP 27-30 Protein as part of broader study in Molecular biology.
His work on Fibrillogenesis as part of general Fibril study is frequently connected to Polymerization, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His most cited work include:
- Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. (3285 citations)
- Amyloid β-peptide is produced by cultured cells during normal metabolism (1763 citations)
- A cellular gene encodes scrapie PrP 27-30 protein (1272 citations)
What are the main themes of his work throughout his whole career to date?
David B. Teplow focuses on Biochemistry, Amyloid, Peptide, Biophysics and Molecular biology.
His research investigates the connection between Biochemistry and topics such as P3 peptide that intersect with issues in Biochemistry of Alzheimer's disease.
His research integrates issues of Fibril, Amyloid beta, Oligomer and Protein folding in his study of Amyloid.
The various areas that David B. Teplow examines in his Peptide study include Stereochemistry, Mutant, Protein secondary structure and Random hexamer.
Nucleation is closely connected to Crystallography in his research, which is encompassed under the umbrella topic of Biophysics.
His study in Molecular biology is interdisciplinary in nature, drawing from both Complementary DNA, Gene, Presenilin and Proteolysis.
He most often published in these fields:
- Biochemistry (42.91%)
- Amyloid (37.93%)
- Peptide (25.67%)
What were the highlights of his more recent work (between 2013-2021)?
- Biophysics (19.54%)
- Amyloid (37.93%)
- Peptide (25.67%)
In recent papers he was focusing on the following fields of study:
David B. Teplow mainly investigates Biophysics, Amyloid, Peptide, Oligomer and Protein structure.
His Biophysics research includes elements of Crystallography, Neurotoxicity and Amyloid β1 42.
His Amyloid research integrates issues from Plasma protein binding, Intracellular, Cell biology, Neurodegeneration and Cognitive decline.
His research on Peptide concerns the broader Biochemistry.
His study in P3 peptide extends to Biochemistry with its themes.
The concepts of his Protein structure study are interwoven with issues in Peptide sequence and Protein folding.
Between 2013 and 2021, his most popular works were:
- High-speed atomic force microscopy reveals structural dynamics of amyloid β1–42 aggregates (83 citations)
- Amyloid β-Protein Assembly and Alzheimer’s Disease: Dodecamers of Aβ42, but Not of Aβ40, Seed Fibril Formation (70 citations)
- Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly (70 citations)
In his most recent research, the most cited papers focused on:
David B. Teplow mainly focuses on Amyloid, Crystallography, Biophysics, Peptide and Oligomer.
His Amyloid research is multidisciplinary, incorporating perspectives in Neurotoxicity, Neurodegeneration, Molecular biology and Cell biology.
His Crystallography research incorporates themes from Fibril, Amyloid β, Amyloid β1 42 and Nucleation.
His Biophysics study integrates concerns from other disciplines, such as Nucleus and Amyloidogenic Proteins.
To a larger extent, he studies Biochemistry with the aim of understanding Peptide.
His Oligomer study incorporates themes from Protein structure and Dimer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
